Home       Privacy       Archive       Realtime Report



Stock Trading History of Homcy Charles J

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Homcy Charles J since year 2005. The trader's CIK number is 1192591. At the time of this reporting, Homcy Charles J is the Director of Millennium Pharmaceuticals Inc (stock ticker symbol MLNM).

Stock purchases, sales, and option exercises reported by Homcy Charles J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-12-11 MLNM Millennium Pharmaceuticals Inc Option Exercise 59,238 6.49 384,454
2007-12-11 MLNM Millennium Pharmaceuticals Inc Sale 59,238 15.81 936,434
2007-09-18 MLNM Millennium Pharmaceuticals Inc Option Exercise 60,831 8.44 513,413
2007-09-17 MLNM Millennium Pharmaceuticals Inc Sale 10,000 9.76 97,635
2007-09-18 MLNM Millennium Pharmaceuticals Inc Sale 40,000 10.33 413,240
2007-09-19 MLNM Millennium Pharmaceuticals Inc Sale 40,000 10.68 427,236
2007-09-05 MLNM Millennium Pharmaceuticals Inc Option Exercise 30,000 8.44 253,199
2007-09-04 MLNM Millennium Pharmaceuticals Inc Sale 30,000 10.20 306,000
2007-02-16 MLNM Millennium Pharmaceuticals Inc Sale 27,774 11.24 312,179
2007-01-23 MLNM Millennium Pharmaceuticals Inc Option Exercise 7,225 6.34 45,806
2007-01-24 MLNM Millennium Pharmaceuticals Inc Option Exercise 2,394 6.34 15,177
2006-11-21 MLNM Millennium Pharmaceuticals Inc Option Exercise 20,000 6.34 126,800
2006-11-21 MLNM Millennium Pharmaceuticals Inc Sale 20,000 11.44 228,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Homcy Charles J (Director of Millennium Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.